 Men and women with idiopathic Parkinsons disease PD who have met inclusion criteria for PRESTO, and have completed the 26-week PRESTO study. The subject should be available to participate in the sub-study immediately following the last PRESTO visit same day. Subjects must continue PRESTO study drug until the morning of the Tyramine Sub-Study. 